Please login to the form below

Aspen Pharma

This page shows the latest Aspen Pharma news and features for those working in and with pharma, biotech and healthcare.

Aspen to pay millions to NHS following drug pricing investigation

South African pharma company Aspen is set to pay the NHS £8m ($9.9m) in the next few weeks, after an investigation by the UK’s Competition and Markets Authority (CMA) ... This acquisition made Aspen the sole owner of all existing fludrocortisone

Latest news

Italian pharma scandals prompts call for EU-wide pricing probe

Aspen fined 5.2m for threat to halt supply of cancer drugs if price hikes not accepted. ... The case against Aspen's Italian subsidiary was first launched in 2014, which according to consumer group Altroconsumo "disappeared from the market after Aspen
GSK sells another chunk of South Africa's Aspen

In the same year, Aspen also took control of a GSK generic drugs unit in Australia and bought one of the UK-based company's manufacturing facilities in France. ... We continue to believe in the strategy of Aspen and we remain committed to working
GSK sells off anticoagulants for £700m

pharma company The Aspen Group. ... In Indonesia, GSK will distribute and market the brands under licence from Aspen.
Sigma to sell pharma division to Aspen

Australian Sigma Pharmaceuticals has agreed to sell its drugs unit to Aspen, Africa's largest drug maker, for A$900m (£513m/$801m). ... The Board has concluded that Aspen's proposal to acquire the pharmaceuticals division is the best alternative for
Aspen and Pfizer Australia face lawsuits

Two pharma firms in Australia face a class action lawsuit following alleged links between Parkinson's treatments and addictive behaviour. ... result of taking Parkinson's treatments Cabaser (cabergoline), made by Pfizer, and Permax (pergolide mesylate),

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Latest Intelligence

A new EU in the making, what lies ahead for pharma?

And the Greens are not really the greatest supporters of the pharma industry…. ... She has been creative in the way she pushed the boundaries of the treaties with, for example, the pricing investigation over Aspen Pharma.
Deal Watch table for October 2014

For an indepth analysis of these deals, read'Pharma deals during October 2014'. ... 130. TesoRx Pharma/Aspen. Licence [C]. For TSX 002 an unmodified oral testosterone replacement.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Medical Editor: Competitive

Healthcare Lead Copywriter: Competitive

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Healthcare Account Director: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Account Director – Creative Healthcare Communications: Competative

Healthcare Senior Account Manager: Competitive

PMHub

Add my company

JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story: How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
Three ways AI will change healthcare in the next decade: Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...